Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01123889
Other study ID # 59322
Secondary ID
Status Completed
Phase N/A
First received April 20, 2010
Last updated December 24, 2013
Start date May 2010
Est. completion date May 2011

Study information

Verified date December 2013
Source Loma Linda University
Contact n/a
Is FDA regulated No
Health authority United States: Food and Drug Administration
Study type Interventional

Clinical Trial Summary

The purpose of this investigator initiated study is to clinically evaluate the efficacy of a new treatment for subacromial impingement syndrome and partial thickness rotator cuff tears. This treatment consists of a platelet rich plasma injection into and around the rotator cuff. It is thought that this treatment will dramatically improve outcomes for patients suffering from these two conditions.

Subjects will be randomized by choosing a slip of paper from an envelope. This process will randomize 25 patients to the experimental group, and 25 patients to the control. The experimental group will undergo a blood draw, allowing for an injection of platelet rich plasma around the rotator cuff. The control group will undergo a corticosteroid injection into the subacromial space surrounding the rotator cuff as sole treatment. Patients will be followed for three months for pain, and will fill out questionnaires at six weeks and three months post injection, which will give insight into functionality and pain changes that the rotator cuff is experiencing due to treatment.

Subjects will be outpatients. Subjects may include employees, students, minorities, and elderly, although no subsets of these will be formed.

Subjects will be between 18 and 89 years of age.

In total, subject participation will last approximately 3 months.


Recruitment information / eligibility

Status Completed
Enrollment 12
Est. completion date May 2011
Est. primary completion date May 2011
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 89 Years
Eligibility Inclusion Criteria:

1. Patients presenting with rotator cuff symptoms for at least 4 weeks

2. Examination reveals diffuse pain with provocative maneuvers

3. Impingement symptoms with or without a partial thickness tear (if available MRI study must be less than 50% tear)

4. Willingness to participate in an investigational technique

5. Willingness to forgo any other concomitant conservative treatment modality including NSAID (must be stopped for at least one week)

Exclusion Criteria:

1. Previous rotator cuff repair

2. Complete rotator cuff tear or two tendon tears

3. Pt w/ complex regional pain syndrome

4. Cervical neuropathy or other nerve pathology

5. RA, local or systemic infection, PVD, metabolic disease such as gout, clotting disorder, anticoagulation therapy

6. Evidence of intraarticular arthritis

7. Work related or compensable injury

8. Previous treatment: corticosteroid injection in the last 6 months

9. Patients who are currently pregnant

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Biological:
platelet rich plasma injection
45 ml of a patient's own blood will be collected via blood draw, maintaining sterile technique. This will then be spun down using a Magellan Autologous Platelet Separator System, yielding platelet rich plasma (PRP). Under sterile conditions, patients will receive a 5 cc PRP injection (consisting of their own PRP) with 1 cc of 1% lidocaine and 1 cc of 0.5% ropivacaine into the subacromial space, administered by an orthopedic surgeon. This will be done using a posterior lateral approach. The patient will be monitored for 10 minutes in clinic for adverse reactions.
Drug:
corticosteroid injection
Under sterile conditions, patients will receive a 5cc injection consisting of 2cc 1% lidocaine, 2cc 0.5% ropivacaine, and 1cc kenalog corticosteroid (40mg/cc) into the subacromial space utilizing a posterior lateral approach. Patients will be observed for 10 min in clinic for any adverse reactions.

Locations

Country Name City State
United States Loma Linda University Loma Linda California

Sponsors (1)

Lead Sponsor Collaborator
Loma Linda University

Country where clinical trial is conducted

United States, 

References & Publications (4)

Blair B, Rokito AS, Cuomo F, Jarolem K, Zuckerman JD. Efficacy of injections of corticosteroids for subacromial impingement syndrome. J Bone Joint Surg Am. 1996 Nov;78(11):1685-9. — View Citation

Buchbinder R, Green S, Youd JM. Corticosteroid injections for shoulder pain. Cochrane Database Syst Rev. 2003;(1):CD004016. Review. — View Citation

Fukuda H. The management of partial-thickness tears of the rotator cuff. J Bone Joint Surg Br. 2003 Jan;85(1):3-11. Review. — View Citation

Mishra A, Pavelko T. Treatment of chronic elbow tendinosis with buffered platelet-rich plasma. Am J Sports Med. 2006 Nov;34(11):1774-8. Epub 2006 May 30. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Pain and Disability of the Shoulder Through Validated Questionnaires Patients will be asked to fill out questionnaires to provide insight into how their condition is progressing, consisting of components of the American Shoulder and Elbow Surgeons (ASES) total score. The maximum score is 100, made up by pain and function components' sums. Only the total score is recorded, 100 being full normal function without pain, 0 being severe pain and no function. 6 weeks from initial injection of corticosteroid versus platelet rich plasma No
Primary Pain and Disability of the Shoulder Through Validated Questionnaires Patients will be asked to fill out questionnaires to provide insight into how their condition is progressing, consisting of components of the American Shoulder and Elbow Surgeons (ASES) total score. The maximum score is 100, made up by pain and function components' sums. Only the total score is recorded, 100 being full normal function without pain, 0 being severe pain and no function. 12 weeks from initial injection of corticosteroid versus platelet rich plasma No
Primary Pain and Disability of the Shoulder Through Validated Questionnaires Patients will be asked to fill out questionnaires to provide insight into how their condition is progressing, consisting of components of the American Shoulder and Elbow Surgeons (ASES) total score. The maximum score is 100, made up by pain and function components' sums. Only the total score is recorded, 100 being full normal function without pain, 0 being severe pain and no function. 15 minutes prior to initial injection of corticosteroid versus platelet rich plasma No
See also
  Status Clinical Trial Phase
Terminated NCT03913702 - Subacromial Methylprednisolone Versus Ketorolac for Shoulder Impingement Phase 2
Completed NCT05071469 - Comparison of Two Different Treatment Methods N/A
Active, not recruiting NCT04660682 - A Comparison of the Long Term Effects of the Traditional and Modified Posterior Shoulder Stretching Exercise in Subacromial Impingement Syndrome N/A
Completed NCT03186287 - Effectiveness of Eccentric and Concentric Strength Training in Patients With Subacromial Impingement Syndrome N/A
Completed NCT04915430 - Training in Subacromial Impingement Syndrome N/A
Recruiting NCT01691157 - Exercise in the Physiotherapy Management of Shoulder Impingement N/A
Completed NCT01753271 - Subacute Effects of Spinal Mobilization to Treat Subacromial Impingement N/A
Withdrawn NCT01449448 - Subacromial Injection With Corticosteroid Versus Nonsteroidal Anti-inflammatory Drugs (NSAID) in Shoulder Impingement Syndrome N/A
Not yet recruiting NCT05794633 - Acupuncture Therapy in Patients With Subacromial Impingement Syndrome N/A
Active, not recruiting NCT06324487 - A New Application in Subacromial Impingement Syndrome N/A
Not yet recruiting NCT06023914 - Analysis of the Effect of Neuromuscular Electro-stimulation on the Performance of Isometric Rotator Cuff Strength. Phase 2/Phase 3
Recruiting NCT04644042 - The Effect of Arthroscopic Subacromial Decompression in Patients Who Are Non-responders to Non-operative Treatment. N/A
Completed NCT04594408 - Tranexamic Acid to Improve Arthroscopic Visualization in Shoulder Surgery Phase 4
Completed NCT05549674 - Copenhagen Cohort of Patients With Shoulder Pain
Completed NCT03888586 - Comparison of Dry Needling and Deep Friction Massage in Patients With Subacromial Pain Syndrome N/A
Completed NCT03303001 - Comparison Between Subacromial Infiltrations N/A
Recruiting NCT03658707 - Validity and Reliability of the Turkish Version of the Functional Shoulder Score
Recruiting NCT02374125 - Teres Major Muscle and Subacromial Impingement Syndrome N/A
Active, not recruiting NCT03326466 - Muscle Function, Central Nervous System Sensitization, and Pain Profiling in Patients With Subacromial Pain (SAP-CNSS).
Completed NCT04169880 - Effects of High Intensity Laser Therapy (HILT) in Patients With Subacromial Impingement Syndrome N/A